|
 |
| Home > Press Room > Saint Joseph’s Translational Research Institute Opens State-Of-The-Art, 32,000-Square-Foot Preclinical Research Facility in the Heart of Atlanta | News| Saint Joseph’s Translational Research Institute Opens State-Of-The-Art, 32,000-Square-Foot Preclinical Research Facility in the Heart of Atlanta | | Industry Leaders Tour Facility during 2009 BIO International Convention | | | Published Tuesday, May 19, 2009 |
ATLANTA – (May 19, 2009) – Saint Joseph’s Translational Research Institute (SJTRI), the research division of Saint Joseph’s Health System, will open its new, state-of-the-art,32,000-square-foot preclinical research facility on May 19, providing international industry leaders the ability to tour the facility during the 2009 BIO International Convention: The Global Event for Biotechnology held May 18-21, 2009 in Atlanta.
As part of a collaboration with the Georgia Institute of Technology, SJTRI is one of the first anchor tenants at Technology Enterprise Park (TEP), a bio-business park adjacent to the Georgia Tech campus in midtown Atlanta. Current tenants also include biotech companies CardioMEMS and Altea Therapeutics.
SJTRI is a private, nonprofit research institute that combines the efficiencies of a commercial contract research organization with the resources of an academic institution. Unlike any other translational research institute, SJTRI employs a mixture of industry and academic staff; provides access to the medical expertise and resources of Saint Joseph’s Health System – locally through Saint Joseph’s Hospital and nationally through Catholic Health East; and now offers cutting-edge facilities for preclinical and clinical studies, physician education and training and regulatory assistance.
“SJTRI is changing how scientists and companies investigate new, innovative health breakthroughs,” said Nicolas Chronos, M.D., president of SJTRI and world-renowned cardiologist. “By bridging academia, private industry, and nonprofit, we serve as a catalyst for collaboration and offer leading clinical solutions and resources to move new devices and therapeutic technologies from bench to bedside faster.”
The new facility offers six surgical suites; two fixed catheterization laboratories; five wet labs for histology, cell and tissue research; a robotic suite; expansive preclinical prep space; offices and real-time, live 24/7 remote access to the laboratories through Georgia Tech’s Global Learning Center. Along with these capabilities, SJTRI’s non-profit status offers customers the opportunity to collaborate on federal funding and grant opportunities, unlike private entities.
SJTRI has already proven its academic, clinical and regulatory expertise through its successes in bringing two commercially approved drug-eluting stents to commercial use, supporting two international pharmaceutical and medical device companies in entering the U.S. market and collaborating on Atlanta-based CardioMEMS’ U.S. Food and Drug Administration (FDA) approval.
SJTRI will be part of the BIO convention by participating in the Georgia Pavilion, booth no. 2817, hosting an open house at the new facility on May 19 and lending Dr. Chronos’ expertise to the breakout session entitled “Stem Cells: Translating Exciting Preclinical Data into Human Clinical Trials” from 2-3:30 p.m. on May 19.
AboutSaint Joseph’s Translational Research Institute
Saint Joseph’s Translational Research Instituteis a private, nonprofit research institute that combines the efficiencies of a commercial contract research organization with the resources of an academic institution. SJTRI was founded as the American Cardiovascular Research Institute by Nicolas Chronos, M.D., in 1999. In 2003, ACRI merged into the Saint Joseph’s Health System providing the vast resources of the Catholic Health East network. While academically focused, SJTRI understands the end goal of bringing devices and therapies to market, which is why half of the SJTRI employees have experience in private industry. SJTRI offers preclinical and clinical resources, regulatory support, collaborative funding opportunities and physician education and training. For more information, visit www.sjtri.org.
|
|
|
|
|
Multimedia